Alnylam Pharmaceuticals (ALNY) Short-term Investments (2009 - 2026)
Alnylam Pharmaceuticals' Short-term Investments came in at $1.6 billion for Q2 2026, down 8.3% from $1.74 billion a year earlier but up 23.2% from the prior quarter.
Powered by 
Analysis
Alnylam Pharmaceuticals (ALNY) Short-term Investments (2009 - 2026) Analysis & Trends
At the end of FY2025, Alnylam Pharmaceuticals' Short-term Investments was $1.25 billion, down 27.3% from FY2024.
- Short-term Investments carries a five-year compound annual growth rate of -1.3% (FY2020 to FY2025).
- Going back by year, Short-term Investments was $1.72 billion in FY2024 (+6.5%), $1.62 billion in FY2023 (+24.5%), $1.3 billion in FY2022 (-16.2%) and $1.55 billion in FY2021 (+16.2%).
- The five-year range for quarterly Short-term Investments is $1.16 billion (Q3 2021) to $1.74 billion (Q2 2025).
- Year-over-year, Short-term Investments has declined for four consecutive quarters, with an average decline of 6.3% over the last eight quarters.
- The fastest year-over-year change in Short-term Investments over five years came in Q2 2022 (growth of 36.5%), and the weakest in Q4 2025 (a decline of 27.3%).
- Business Quant data shows ALNY's Short-term Investments at $1.3 billion (Q1 2026), $1.25 billion (Q4 2025) and $1.23 billion (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 653.54 Bn | 572.07 Bn | 17.26 Bn |
| 2 | AbbVie | 467.01 Bn | 440.17 Bn | 12.70 Bn |
| 3 | Merck | 367.16 Bn | 321.59 Bn | 12.21 Bn |
| 4 | Novartis Ag | 277.56 Bn | 233.43 Bn | 11.24 Bn |
| 5 | Astrazeneca | 258.23 Bn | 231.79 Bn | 12.86 Bn |
| 6 | Amgen | 224.14 Bn | 179.54 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 187.30 Bn | 161.42 Bn | 6.22 Bn |
| 8 | Pfizer | 163.47 Bn | 110.41 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 133.31 Bn | 105.31 Bn | 2.84 Bn |
| 10 | Alnylam Pharmaceuticals | 34.23 Bn | 22.28 Bn | 992.69 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.60 Bn |
| Mar 31, 2026 | 1.30 Bn |
| Dec 31, 2025 | 1.25 Bn |
| Sep 30, 2025 | 1.23 Bn |
| Jun 30, 2025 | 1.74 Bn |
| Mar 31, 2025 | 1.61 Bn |
| Dec 31, 2024 | 1.72 Bn |
| Sep 30, 2024 | 1.67 Bn |
| Jun 30, 2024 | 1.65 Bn |
| Mar 31, 2024 | 1.68 Bn |
| Dec 31, 2023 | 1.62 Bn |
| Sep 30, 2023 | 1.36 Bn |
| Jun 30, 2023 | 1.37 Bn |
| Mar 31, 2023 | 1.37 Bn |
| Dec 31, 2022 | 1.30 Bn |
| Sep 30, 2022 | 1.17 Bn |
| Jun 30, 2022 | 1.50 Bn |
| Mar 31, 2022 | 1.67 Bn |
| Dec 31, 2021 | 1.55 Bn |
| Sep 30, 2021 | 1.16 Bn |
API Access
Alnylam Pharmaceuticals Short-term Investments API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=short-term-investments&ticker=ALNY&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "short-term-investments", "ticker": "ALNY", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=short-term-investments&ticker=ALNY&period=max&api_key=YOUR_API_KEY");
const data = await res.json();